Researchers at McMaster University have determined that a widely available and inexpensive medication, Pantoprazole, not only prevents serious stomach bleeding in critically ill patients but also saves hospitals thousands of dollars.
The study, published in the journal JAMA Network Open, is the first to substantiate both the clinical and economic benefits of Pantoprazole. The medication is intended for patients on mechanical ventilation in Intensive Care Units (ICUs).
ICU patients are under acute physical stress, such as sepsis, multiple trauma, or organ failure. Such severe conditions lead to the development of stress ulcers—acute damage to the gastrointestinal tract—which creates a high risk of bleeding.
This risk of stress ulcers includes specific forms:
-
Curling’s ulcer, which develops during severe burns due to low blood supply (perfusion) to the mucous membrane.
-
Cushing’s ulcer, which is caused by the excessive secretion of stomach acid following severe head trauma or increased intracranial pressure.
Such complications significantly increase the length of hospitalization and treatment costs, making the prophylactic use of Pantoprazole critically important.
According to the authors of the scientific paper, in an era where healthcare costs are constantly rising, interventions that are simultaneously clinically effective and cost-saving are rare. Pantoprazole meets both of these requirements.
These findings are based on a large-scale study conducted previously, which had already confirmed the clinical effectiveness of Pantoprazole in preventing bleeding.
The economic analysis was conducted using international data. Although a single dose of Pantoprazole costs between 50 cents and two dollars across the United States, the analysis showed that prescribing it to patients on invasive ventilation:
-
Reduces bleeding episodes.
-
Reduces the overall length of hospital stay.
Ultimately, this simple and low-cost drug not only improves patient clinical outcomes but also saves hospitals thousands of dollars. The research confirms that effective medicine does not always require high costs.
